Concepedia
Author
Yumi Yamashita-Kanemaru
Also Known As
18
Publications
323
Citations
8
H-Index
0
Concepts
All Affiliations
×
All Concepts
308
Tumor-derived soluble CD155 inhibits DNAM-1–mediated antitumor activity of natural killer cells
Genki Okumura, Akiko Iguchi‐Manaka, Rikito Murata, +3
The Journal of Experimental Medicine
2020
95
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity
Jie Yang, Yumi Yamashita-Kanemaru, Benjamin I. Morris, +32
Nature
2025
70
DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions
Yumi Yamashita-Kanemaru, Fumie Abe, Rikito Murata, +8
Proceedings of the National Academy of Sciences
2021
46
Selective DNAM-1 expression on small peritoneal macrophages contributes to CD4+ T cell costimulation
Eri Takenaka, Anh Van Vo, Yumi Yamashita-Kanemaru, +2
Scientific Reports
2018
26
Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice
Yoko Nagumo, Akiko Iguchi‐Manaka, Yumi Yamashita-Kanemaru, +4
PLoS ONE
2014
25
CD155 (PVR/Necl5) Mediates a Costimulatory Signal in CD4+ T Cells and Regulates Allergic Inflammation
Yumi Yamashita-Kanemaru, Yuichi Takahashi, Yinan Wang, +5
The Journal of Immunology
2015
22
Physiological function of phospholipase D2 in anti-tumor immunity: regulation of CD8+ T lymphocyte proliferation
Van Ngo Thai Bich, Tsunaki Hongu, Yuki Miura, +6
13
CD155-Transducing Signaling through TIGIT Plays an Important Role in Transmission of Tolerant State and Suppression Capacity
Naoko Negishi, Takehito Sato, Yumi Yamashita-Kanemaru, +7
ImmunoHorizons
11
Page 1